Targeted in vitro photodynamic therapy via aptamer-labeled, porphyrin-loaded virus capsids

Journal of Photochemistry and Photobiology B: Biology

Volumn 121, Issue , 2013, Pages 67-74

  Cohen, Brian A ^a   Bergkvist, Magnus ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Aptamer; Breast cancer; Nanoparticles; Porphyrin; Targeted photodynamic therapy; Virus

Indexed keywords

APTAMER; PHOTOSENSITIZING AGENT; PORPHYRIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL ASSAY; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MS2 VIRUS; NONHUMAN; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; STAINING; VIRUS CAPSID;

APTAMERS, NUCLEOTIDE; BREAST NEOPLASMS; CAPSID PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MCF-7 CELLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

MIRIDAE;

EID: 84875073935     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2013.02.013     Document Type: Article

References (42)

1. N. Howlader, A.M. Noone, M. Krapcho, N. Neyman, R. Aminou, W. Waldron, S.F. Altekruse, C.L. Kosary, J. Ruhl, Z. Tatalovich, H. Cho, A. Mariotto, M.P. Eisner, D.R. Lewis, H.S. Chen, E.J. Feuer, K.A. Cronin, B.K. Edwards, SEER Cancer Statistics Review, in: N.C. Institute (Ed.), NCI, Bethesda, MD, 2011.
2. M.D. Daniell, and J.S. Hill A history of photodynamic therapy Aust. N. Z. J. Surg. 61 1991 340 348
3. M.L. Davila Photodynamic therapy Gastrointest. Endosc. Clin. North Am. 21 2011 67 79
4. S.-i. Ogura, K. Tabata, K. Fukushima, T. Kamachi, and I. Okura Development of phthalocyanines for photodynamic therapy J. Porphyr. Phthalocya. 10 2006 1116 1124
5. I. Sehgal, M. Sibrian-Vazquez, and M.G. Vicente Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins J. Med. Chem. 51 2008 6014 6020
6. J. Gravier, R. Schneider, C. Frochot, T. Bastogne, F. Schmitt, J. Didelon, F. Guillemin, and M. Barberi-Heyob Improvement of meta- tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. synthesis and in vivo delivery studies J. Med. Chem. 51 2008 3867 3877
7. E. Paszko, C. Ehrhardt, M.O. Senge, D.P. Kelleher, and J.V. Reynolds Nanodrug applications in photodynamic therapy Photodiagn. Photodyn. Ther. 8 2011 14 29
8. Y. Wu, K. Sefah, H. Liu, R. Wang, and W. Tan DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells Proc. Nat. Acad. Sci. 107 2010 5 10
9. L.A. Lee, and Q. Wang Adaptations of nanoscale viruses and other protein cages for medical applications Nanomedicine 2 2006 137 149
10. H.S. Leong, N.F. Steinmetz, A. Ablack, G. Destito, A. Zijlstra, H. Stuhlmann, M. Manchester, and J.D. Lewis Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles Nat. Protoc. 5 2010 1406 1417
11. M. Bergkvist, and B. Cohen Virus-Based Nanotechnology Y. Xie, The Nanobiotechnology Handbook 2013 CRC Press Boca Raton, FL
12. D.J. Evans The bionanoscience of plant viruses: templates and synthons for new materials J. Mater. Chem. 18 2008 3746 3754
13. D.J. Evans Exploitation of plant and archaeal viruses in bionanotechnology Biochem. Soc. Trans. 37 2009 665 670
14. J.D. Lewis, G. Destito, A. Zijlstra, M.J. Gonzalez, J.P. Quigley, M. Manchester, and H. Stuhlmann Viral nanoparticles as tools for intravital vascular imaging Nat. Med. 12 2006 354 360
15. M. Manchester, and P. Singh Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging Adv. Drug Deliv. Rev. 58 2006 1505 1522
16. T.L. Schlick, Z. Ding, E.W. Kovacs, and M.B. Francis Dual-surface modification of the tobacco mosaic virus J. Am. Chem. Soc. 127 2005 3718 3723
17. E. Gillitzer, D. Willits, M. Young, and T. Douglas Chemical modification of a viral cage for multivalent presentation Chem. Commun. 2002 2390 2391
18. D.S. Peabody A viral platform for chemical modification and multivalent display J. Nanobiotechnol. 1 2003 1 8
19. Q. Zeng, S. Saha, L.A. Lee, H. Barnhill, J. Oxsher, T. Dreher, and Q. Wang Chemoselective modification of turnip yellow mosaic virus by Cu(I) catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction and its application in cell binding Bioconjug. Chem. 22 2011 58 66
20. B.A. Cohen, A.E. Kaloyeros, and M. Bergkvist Nucleotide-driven packaging of a singlet oxygen generating porphyin in an icosahedral virus J. Porphyr. Phthalocya. 16 2012 47 54
21. K. Valegard, L. Liljas, K. Fridborg, and T. Unge The three-dimensional structure of the bacterial virus MS2 Nature 345 1990 36 41
22. K. Toropova, P.G. Stockley, and N.A. Ranson Visualising a viral RNA genome poised for release from its receptor complex J. Mol. Biol. 408 2011 408 419
23. K. Toropova, G. Basnak, R. Twarock, P.G. Stockley, and N.A. Ranson The three-dimensional structure of genomic RNA in bacteriophage MS2: implications for assembly J. Mol. Biol. 375 2008 824 836
24. B.A. Cohen, A.E. Kaloyeros, M. Bergkvist, MS2 bacteriophage as a delivery vessel of porphyrins for photodynamic therapy, in: Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XX, SPIE, San Francisco, California, USA, 2011, pp. 788614-788617.
25. J. Verlhac, A. Gaudemer, and I. Kraljic Water-soluble porphyrins and metalloporphyrins as photosensitizers in aerated aqueous solutions. I. Detection and determination of quantum yield of formation of singlet oxygen Nouv. J. Chim. 8 1984 401 406
26. M. Merchat, G. Bertolini, P. Giacomini, A. Villanueva, and G. Jori Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria J. Photochem. Photobiol. B 32 1996 153 157
27. C.-A. Bristow, R. Hudson, T.A. Paget, and R.W. Boyle Potential of cationic porphyrins for photodynamic treatment of cutaneous Leishmaniasis Photodiagn. Photodyn. Ther. 3 2006 162 167
28. A.G. Hovanessian, C. Soundaramourty, D. El Khoury, I. Nondier, J. Svab, and B. Krust Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization PLoS ONE 5 2010 e15787
29. D. El Khoury, D. Destouches, R. Lengagne, B. Krust, Y. Hamma-Kourbali, M. Garcette, S. Niro, M. Kato, J.P. Briand, J. Courty, A.G. Hovanessian, and A. Prevost-Blondel Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice BMC Cancer 10 2010 325
30. Y.A. Shieh, S.J. Yang, M.F. Wei, and M.J. Shieh Aptamer-based tumor-targeted drug delivery for photodynamic therapy ACS Nano 4 2010 1433 1442
31. E.M. Reyes-Reyes, Y. Teng, and P.J. Bates A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism Cancer Res. 70 2010 8617 8629
32. S. Soundararajan, W. Chen, E.K. Spicer, N. Courtenay-Luck, and D.J. Fernandes The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells Cancer Res. 68 2008 2358 2365
33. S. Soundararajan, L. Wang, V. Sridharan, W. Chen, N. Courtenay-Luck, D. Jones, E.K. Spicer, and D.J. Fernandes Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells Mol. Pharmacol. 76 2009 984 991
34. C.C. Frazier, R.F. Kline, and D.D. Barck Photosubstitution reactivity of carbon disulfide complexes of zerovalent iron Inorg. Chem. 20 1981 4009 4011
35. M. del Toro, R. Gargallo, R. Eritja, and J. Jaumot Study of the interaction between the G-quadruplex-forming thrombin-binding aptamer and the porphyrin 5,10,15,20-tetrakis-(N-methyl-4-pyridyl)-21,23H-porphyrin tetratosylate Anal. Biochem. 379 2008 8 15
36. I.J. Macdonald, and T.J. Dougherty Basic principles of photodynamic therapy J. Porphyr. Phthalocya. 5 2001 105 129
37. T.J. Dougherty, C.J. Gomer, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng Photodynamic therapy J. Natl Cancer Inst. 90 1998 889 905
38. M. Ethirajan, Y. Chen, P. Joshi, and R.K. Pandey The role of porphyrin chemistry in tumor imaging and photodynamic therapy Chem. Soc. Rev. 2010
39. Y.N. Konan, M. Berton, R. Gurny, and E. Allmann Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles Eur. J. Pharm. Sci. 18 2003 241 249
40. A. Roby, S. Erdogan, and V.P. Torchilin Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro Eur. J. Pharm. Biopharm. 62 2006 235 240
41. P.J. Bates, D.A. Laber, D.M. Miller, S.D. Thomas, and J.O. Trent Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer Exp. Mol. Pathol. 86 2009 151 164
42. L.L. Colombo, A. Juarranz, M. Cañete, A. Villanueva, and J.C. Stockert Photodynamic therapy of the murine LM3 tumor using meso-tetra(4-N, N, N-trimethylanilinium)Porphine Int. J. Biomed. Sci. 3 2007 258 262